Page 236 - IJB-10-3
P. 236

International

                                                                         Journal of Bioprinting



                                        RESEARCH ARTICLE
                                        Increased stiffness of extracellular matrix

                                        enhanced chemoresistance in 3D-bioprinted
                                        ovarian cancer model



                                        Ying Shan , Mingchang Pang , Liqian Wang , Yixin Mao , Ruiyi Yan , Chang
                                                1†
                                                                 2†
                                                                                         4†
                                                                                                   2
                                                                              3†
                                        Zhou , Jingyuan Ji , Yilei Mao , Ying Jin *, and Huayu Yang *
                                                        5
                                            5
                                                                 2
                                                                                          2
                                                                         1
                                        1  Department of Obstetrics and Gynecology, National  Clinical  Research Center for Obstetric &
                                        Gynecologic Diseases,  Peking Union Medical College Hospital, Chinese  Academy of  Medical
                                        Sciences & Peking Union Medical College, Beijing, China
                                        2  Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical
                                        Sciences & Peking Union Medical College, Beijing, China
                                        3   Department  of  Gynecology, The Affiliated Yantai Yuhuangding  Hospital  of  Qingdao  University,
                                        Yantai, China
                                        4  Department of Geriatrics, Shanghai Eighth Peoples Hospital, Shanghai, China
                                        5  Biomanufacturing Center, Department of Mechanical Engineering, Tsinghua University, Beijing,
                                        China
                                        (This article belongs to the Special Issue: Bioprinting process for tumor model development)
                                        Abstract
                                        Ovarian cancer is a gynecological malignancy with a high mortality rate. The ovarian
                                        cancer microenvironment is a crucial factor affecting the overall and progression-free
            † These authors contributed equally   survival rates of patients with ovarian cancer. The biophysical factors of the tumor
            to this work.
                                        microenvironment, such as stiffness, can affect the gene expression and behavior of
            *Corresponding authors:     tumor cells. In this study, we utilized 3D bioprinting technology to construct ovarian
            Huayu Yang
            (dolphinyahy@hotmail.com)   cancer tumor models with varying levels of stiffness in vitro to investigate the effect of
            Ying Jin (jinying@pumch.cn)  extracellular matrix stiffness on drug resistance of tumor cells. Our findings indicate
                                        that increasing the stiffness of extracellular matrix can attenuate the sensitivity of
            Citation: Shan Y, Pang M, Wang   tumor cells to chemotherapeutic agents. Additionally, the increased stiffness of 3D
            L, et al. Increased stiffness of
            extracellular matrix enhanced   tumor model may promote malignant phenotypes, such as tumor stemness and
            chemoresistance in 3D-bioprinted   tumor progression.
            ovarian cancer model. Int J Bioprint.
            2024;10(3):1673.
            doi: 10.36922/ijb.1673      Keywords: 3D bioprinting technology; Ovarian cancer; Tumor microenvironment;
            Received: August 24, 2023   Stiffness; Drug resistance
            Accepted: November 21, 2023
            Published Online: January 18, 2024
            Copyright: © 2024 Author(s).
            This is an Open Access article   1. Introduction
            distributed under the terms of the
            Creative Commons Attribution   Ovarian cancer is the most fatal gynecological malignancy with a high mortality/
            License, permitting distribution,
            and reproduction in any medium,   morbidity ratio primarily attributed to the lack of specific symptoms and effective early
            provided the original work is   screening strategies.  Despite advances in cancer treatment, survival rates for ovarian
                                                        1
            properly cited.             cancer have remained largely unchanged, even in medically advanced countries such
            Publisher’s Note: AccScience   as the United States and Canada, where only about 47% of patients survive five years
            Publishing remains neutral with   after diagnosis.  Currently, cytoreductive surgery and cisplatin-based chemotherapy
                                                    2
            regard to jurisdictional claims in                            3,4
            published maps and institutional   remain the preferred treatment options,  while the continuous development and
            affiliations.               updates in immunotherapy, targeted therapy, and combinatorial chemotherapy offer

            Volume 10 Issue 3 (2024)                       228                                doi: 10.36922/ijb.1673
   231   232   233   234   235   236   237   238   239   240   241